SPL 2.08% 9.8¢ starpharma holdings limited

Ann: VivaGel BV phase 3 trials for prevention of BV completed, page-15

  1. 426 Posts.
    lightbulb Created with Sketch. 40
    "As we look forward to the release of results in the next quarter, we are in parallel preparing our US FDA marketing applications, and are engaged in active negotiations for commercial rights to VivaGel® BV."  The company can't say Phase 3 was successful until the results are tabulated, but their actions are screaming "Success at last!"  This is huge and "the market" has it wrong.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.8¢
Change
0.002(2.08%)
Mkt cap ! $40.90M
Open High Low Value Volume
9.7¢ 9.9¢ 9.7¢ $65.08K 662.7K

Buyers (Bids)

No. Vol. Price($)
1 36445 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 64440 3
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.